Literature DB >> 21176882

Research challenges in central nervous system manifestations of inborn errors of metabolism.

P I Dickson1, A R Pariser, S C Groft, R W Ishihara, D E McNeil, D Tagle, D J Griebel, S G Kaler, J W Mink, E G Shapiro, K J Bjoraker, L Krivitzky, J M Provenzale, A Gropman, P Orchard, G Raymond, B H Cohen, R D Steiner, S F Goldkind, R M Nelson, E Kakkis, M C Patterson.   

Abstract

The Research Challenges in CNS Manifestations of Inborn Errors of Metabolism workshop was designed to address challenges in translating potential therapies for these rare disorders, and to highlight novel therapeutic strategies and innovative approaches to CNS delivery, assessment of effects and directions for the future in the treatment of these diseases. Therapies for the brain in inborn errors represent some of the greatest challenges to translational research due to the special properties of the brain, and of inborn errors themselves. This review covers the proceedings of this workshop as submitted by participants. Scientific, ethical and regulatory issues are discussed, along with ways to measure outcomes and the conduct of clinical trials. Participants included regulatory and funding agencies, clinicians, scientists, industry and advocacy groups. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2010        PMID: 21176882      PMCID: PMC3040279          DOI: 10.1016/j.ymgme.2010.11.164

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  39 in total

1.  Transplantation of umbilical-cord blood in babies with infantile Krabbe's disease.

Authors:  Maria L Escolar; Michele D Poe; James M Provenzale; Karen C Richards; June Allison; Susan Wood; David A Wenger; Daniel Pietryga; Donna Wall; Martin Champagne; Richard Morse; William Krivit; Joanne Kurtzberg
Journal:  N Engl J Med       Date:  2005-05-19       Impact factor: 91.245

Review 2.  Globoid cell leukodystrophy: distinguishing early-onset from late-onset disease using a brain MR imaging scoring method.

Authors:  D J Loes; C Peters; W Krivit
Journal:  AJNR Am J Neuroradiol       Date:  1999-02       Impact factor: 3.825

Review 3.  The future for treatment by bone marrow transplantation for adrenoleukodystrophy, metachromatic leukodystrophy, globoid cell leukodystrophy and Hurler syndrome.

Authors:  W Krivit; L A Lockman; P A Watkins; J Hirsch; E G Shapiro
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

4.  Hurler syndrome: II. Outcome of HLA-genotypically identical sibling and HLA-haploidentical related donor bone marrow transplantation in fifty-four children. The Storage Disease Collaborative Study Group.

Authors:  C Peters; E G Shapiro; J Anderson; P J Henslee-Downey; M R Klemperer; M J Cowan; E F Saunders; P A deAlarcon; C Twist; J B Nachman; G A Hale; R E Harris; M K Rozans; J Kurtzberg; G H Grayson; T E Williams; C Lenarsky; J E Wagner; W Krivit
Journal:  Blood       Date:  1998-04-01       Impact factor: 22.113

5.  Long-term outcome of Hurler syndrome following bone marrow transplantation.

Authors:  C B Whitley; K G Belani; P N Chang; C G Summers; B R Blazar; M Y Tsai; R E Latchaw; N K Ramsay; J H Kersey
Journal:  Am J Med Genet       Date:  1993-04-15

6.  Occipital horn syndrome and a mild Menkes phenotype associated with splice site mutations at the MNK locus.

Authors:  S G Kaler; L K Gallo; V K Proud; A K Percy; Y Mark; N A Segal; D S Goldstein; C S Holmes; W A Gahl
Journal:  Nat Genet       Date:  1994-10       Impact factor: 38.330

7.  Adrenoleukodystrophy: a scoring method for brain MR observations.

Authors:  D J Loes; S Hite; H Moser; A E Stillman; E Shapiro; L Lockman; R E Latchaw; W Krivit
Journal:  AJNR Am J Neuroradiol       Date:  1994-10       Impact factor: 3.825

8.  Cord-blood transplants from unrelated donors in patients with Hurler's syndrome.

Authors:  Susan L Staba; Maria L Escolar; Michele Poe; Young Kim; Paul L Martin; Paul Szabolcs; June Allison-Thacker; Susan Wood; David A Wenger; Pablo Rubinstein; John J Hopwood; William Krivit; Joanne Kurtzberg
Journal:  N Engl J Med       Date:  2004-05-06       Impact factor: 91.245

Review 9.  Neuropsychological outcomes of several storage diseases with and without bone marrow transplantation.

Authors:  E G Shapiro; L A Lockman; M Balthazor; W Krivit
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

Review 10.  Krabbe disease: genetic aspects and progress toward therapy.

Authors:  D A Wenger; M A Rafi; P Luzi; J Datto; E Costantino-Ceccarini
Journal:  Mol Genet Metab       Date:  2000-05       Impact factor: 4.797

View more
  13 in total

1.  Clinical trials in rare disease: challenges and opportunities.

Authors:  Erika F Augustine; Heather R Adams; Jonathan W Mink
Journal:  J Child Neurol       Date:  2013-09       Impact factor: 1.987

2.  Correlation of diffusion tensor imaging parameters in the canine brain.

Authors:  Dalun Leong; Evan Calabrese; Leonard E White; Peter Wei; Steven Chen; Simon R Platt; James M Provenzale
Journal:  Neuroradiol J       Date:  2015-02

3.  Methodology of clinical research in rare diseases: development of a research program in juvenile neuronal ceroid lipofuscinosis (JNCL) via creation of a patient registry and collaboration with patient advocates.

Authors:  Elisabeth A de Blieck; Erika F Augustine; Frederick J Marshall; Heather Adams; Jennifer Cialone; Leon Dure; Jennifer M Kwon; Nicole Newhouse; Katherine Rose; Paul G Rothberg; Amy Vierhile; Jonathan W Mink
Journal:  Contemp Clin Trials       Date:  2013-04-26       Impact factor: 2.226

4.  Delivering drugs to the central nervous system: an overview.

Authors:  Patricia I Dickson
Journal:  Drug Deliv Transl Res       Date:  2012-06       Impact factor: 4.617

5.  Use of the Vineland-3, a measure of adaptive functioning, in CLN3.

Authors:  An N Dang Do; Audrey E Thurm; Cristan A Farmer; Ariane G Soldatos; Colby E Chlebowski; Julie K O'Reilly; Forbes D Porter
Journal:  Am J Med Genet A       Date:  2021-12-16       Impact factor: 2.578

6.  Myelin and Lipid Composition of the Corpus Callosum in Mucopolysaccharidosis Type I Mice.

Authors:  Steven Q Le; Igor Nestrasil; Shih-Hsin Kan; Martin Egeland; Jonathan D Cooper; David Elashoff; Rong Guo; Jakub Tolar; Jennifer K Yee; Patricia I Dickson
Journal:  Lipids       Date:  2020-06-14       Impact factor: 1.880

7.  Segmentation of the canine corpus callosum using diffusion-tensor imaging tractography.

Authors:  Theodore T Pierce; Evan Calabrese; Leonard E White; Steven D Chen; Simon R Platt; James M Provenzale
Journal:  AJR Am J Roentgenol       Date:  2014-01       Impact factor: 3.959

8.  Cohort study of neurocognitive functioning and adaptive behaviour in children and adolescents with Niemann-Pick Disease type C1.

Authors:  Audrey Thurm; Cristan Farmer; Nicole Yanjanin Farhat; Edythe Wiggs; David Black; Forbes D Porter
Journal:  Dev Med Child Neurol       Date:  2015-11-19       Impact factor: 5.449

9.  Seizure phenotype in CLN3 disease and its relation to other neurologic outcome measures.

Authors:  Myriam Abdennadher; Sara Inati; Ariane Soldatos; Gina Norato; Eva H Baker; Audrey Thurm; Luca Bartolini; Ruturaj Masvekar; William Theodore; Bibiana Bielekova; Forbes D Porter; An N Dang Do
Journal:  J Inherit Metab Dis       Date:  2021-02-15       Impact factor: 4.750

10.  Value-based reimbursement decisions for orphan drugs: a scoping review and decision framework.

Authors:  Mike Paulden; Tania Stafinski; Devidas Menon; Christopher McCabe
Journal:  Pharmacoeconomics       Date:  2015-03       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.